These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36561615)

  • 41. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proinflammatory cytokines cause down-regulation of renal chloride entry pathways during sepsis.
    Schmidt C; Höcherl K; Schweda F; Bucher M
    Crit Care Med; 2007 Sep; 35(9):2110-9. PubMed ID: 17855824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Programmed Cell Death in Diabetic Nephropathy: A Review of Apoptosis, Autophagy, and Necroptosis.
    Erekat NS
    Med Sci Monit; 2022 Aug; 28():e937766. PubMed ID: 35989481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
    Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
    Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria.
    Tanaka M; Furuhashi M; Moniwa N; Maeda T; Takizawa H; Matsumoto M; Sakai A; Higashiura Y; Gocho Y; Koyama M; Ogawa Y; Miura T
    BMC Nephrol; 2020 Nov; 21(1):459. PubMed ID: 33143633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetic Proteinuria Revisited: Updated Physiologic Perspectives.
    Heyman SN; Raz I; Dwyer JP; Weinberg Sibony R; Lewis JB; Abassi Z
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chapter Five - Ubiquitination of Ion Channels and Transporters.
    Lamothe SM; Zhang S
    Prog Mol Biol Transl Sci; 2016; 141():161-223. PubMed ID: 27378758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Why is proteinuria such an important risk factor for progression in clinical trials?
    Jerums G; Panagiotopoulos S; Tsalamandris C; Allen TJ; Gilbert RE; Comper WD
    Kidney Int Suppl; 1997 Dec; 63():S87-92. PubMed ID: 9407431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Permissive role of hypertension in the development of proteinuria and progression of renal disease in insulin-dependent diabetic patients.
    Earle KA; Morocutti A; Viberti G
    J Hypertens; 1997 Feb; 15(2):191-6. PubMed ID: 9469795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteinuria predicts postcardiotomy acute kidney injury in patients with preserved glomerular filtration rate.
    Li SY; Chuang CL; Yang WC; Lin SJ
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):894-9. PubMed ID: 25433643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid decline of renal function in patients with type 2 diabetes with heavy proteinuria: a report of three cases.
    Lim CTS; Nordin NZ; Fadhlina NZ; Anim MS; Kalaiselvam T; Haikal WZ; Goh BL
    BMC Nephrol; 2019 Jan; 20(1):22. PubMed ID: 30651084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
    Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
    BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
    Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
    Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A nationwide study of mass urine screening tests on Korean school children and implications for chronic kidney disease management.
    Cho BS; Hahn WH; Cheong HI; Lim I; Ko CW; Kim SY; Lee DY; Ha TS; Suh JS
    Clin Exp Nephrol; 2013 Apr; 17(2):205-10. PubMed ID: 23135862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy.
    Smith AC; Toto R; Bakris GL
    Kidney Int; 1998 Sep; 54(3):889-96. PubMed ID: 9734613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ion channels and transporters in the electroreceptive ampullary epithelium from skates.
    Lu J; Fishman HM
    Biophys J; 1995 Dec; 69(6):2467-75. PubMed ID: 8599653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nephrotic-range proteinuria in patients with renovascular disease.
    Halimi JM; Ribstein J; Du Cailar G; Mimran A
    Am J Med; 2000 Feb; 108(2):120-6. PubMed ID: 11126305
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.